Search Results
Results found for "Tao Che"
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
If you want to check out the Materials and Methods section as well as the application note, here is the
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Chemical structure of [3H-CP-55940]. with even more diversity in chemical structures and affinities for other receptors. If you want to read the materials and methods section check out the link to the full article. Chem. Chem. 2006 , 49 (1), 70–79. https://doi.org/10.1021/jm050467q .
- Radioligands vs. Fluorescent Ligands: Binding Assays
They have several advantages, such as the minimal chemical modifications in the original ligand, high Tritium (3H) labeled ligands are usually chemically identical to the original, because tritium will usually specific activity, but a shorter half-life (60 days), which complicates storage, besides changing the chemical
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
determined to be 30.1 ± 1.7 nM corresponding to apparent Ki ± SEM = 15.7 ± 0.9 nM according to the Cheng-Prusoff Journal of Biological Chemistry 2005 , 280 (3), 2176–2185. https://doi.org/10.1074/jbc.M410385200 Chem. 2022 , 65 (6), 4832–4853. https://doi.org/10.1021/acs.jmedchem.1c02033 . (18) Dempsey, C.; Chen, K. H.; Bates, M.; Zhuang, X.
- Conjugation Strategies for Probe Development
This is Lucía from the Celtarys Research chemistry team. You can check what we do here on our website! In Comprehensive Analytical Chemistry ; Verma, S. K., Das, A. Bioconjugate Chem. 2015 , 26 (1), 145–152. https://doi.org/10.1021/bc5005262 . Chem. Rev. 2008 , 108 (8), 2952–3015. https://doi.org/10.1021/cr0783479 .
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Bring in a computational chemist. Add a data scientist. Surely more hands will move the needle.
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
That’s where computational chemistry steps in. This case study highlights why computational chemistry is no longer a side tool—it’s a driver of discovery
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
You’ll see how this manifests in real data from muscarinic receptors, CCR5 chemokine programs, and NMDA
- Your GPCR Program Decisions Depend on Good Data Interpretation
GPCR University Learner Celtarys Research Recap: Medicinal Chemistry Highlights You May Have Missed The pace of innovation in medicinal chemistry is accelerating—and if you missed this year’s ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 , you’re already behind.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
. 🔍 This Week in Premium: Sneak Peek Industry insights: Strategic biotech alliances (Chemspace/Enamine
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
He shares his journey into computational chemistry and offers a compelling look at how tools like AlphaFold
- Understanding Orthosteric Binding: The Key to Drug Action
It’s about a dynamic dance of chemical forces, equilibrium shifts, and molecular decisions that determine The dynamic interplay of chemical forces shapes drug effectiveness.
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases and checkpoint
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine Read The Full Article GPCR Publication Highlights Chemokine–GPCR Selectivity Unveiled Sequence- and structure-based analysis reveals how conserved and variable regions across chemokines and their receptors
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
Here’s the surprising truth: up to 80% of GPCR-targeted drugs fail—not because of poor chemistry, but
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Blocking this chemokine axis reduces pain hypersensitivity by dampening neuroinflammation and glial
- Pharmacology Isn't What You Think—It's So Much More
You’ll uncover: Why pharmacology is the glue between chemistry and biology How to interpret drug behavior
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands using a modular chemistry But what sets them apart isn’t just chemistry. It’s empathy. Democratize access to high-performance chemical probes and make assay development faster, cheaper, and
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
GPCR Partner Tools The Story Behind Celtarys – From Chemistry to Company How does a medicinal chemist
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology “This partnership will help accelerate the adoption of our chemical tools and foster collaborations that Celtarys Research is a biotech company based in Spain that specializes in the development of optimal chemical Their proprietary chemistry platform enables rapid generation of conjugates, such as labeled ligands,
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Check out our new on-demand course on non-canonical GPCR behaviors and a podcast episode tracing 30 years
- Ben Clements on Rescuing Opioids with GPCR Modulators
With collaborations across medicinal chemistry and neuropathic pain research, Ben is bridging molecule
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. GPCR University Cheatsheet is your quick-start guide to everything we offer—no downloads, no digging Explore the Cheatsheet GPCR Publication Highlights — Minimal Structural Variation of GPR84 Full Agonist
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain Regulation of the chemokine
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Hauser Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR Jun Xu , Geng Chen To fully explore our Ecosystem, scroll to the footer and check out our Map! We're about to reveal our University CheatSheet —a sneaky peek at all our talks, presentations, and courses XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry receptor probed by molecular dynamics simulations, NMR and pharmacological studies High-affinity ELR+ chemokine
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
🕵️♂️We'll soon be unveiling our University CheatSheet! Major Announcement! XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry receptor GPR68 supports AML cells through the calcium/calcineurin pro-survival pathway and confers chemoresistance obesity and skeletal muscle dysfunction via improving skeletal muscle Srl/MRCC-I pathway in Drosophila Chemogenetic
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
XXIII GEM Meeting in 2025 April 3 - 6, 2025 | ASPET 2025 April 14 - 17, 2025 | 20th Drug Discovery Chemistry GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic NEW Senior Principal Scientist, Medicinal Chemistry cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
This data can guide the modification of the chemical structure of the lead compounds to improve potency
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
al. for their excellent work on Receptor determinants for ß-arrestin functional specificity at C-X-C chemokine Meeting in 2025 NEW April 3 - 6, 2025 | ASPET 2025 NEW April 14 - 17, 2025 | 20th Drug Discovery Chemistry cell function Protein Biochemist/Structural Biologist Senior Scientist/Staff Scientist, Computational Chemistry like and β2 adrenergic receptors Receptor determinants for ß-arrestin functional specificity at C-X-C chemokine receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development Chemokine






























